World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
13594
World Ranking
3596
National Ranking
1665

Sujan Shresta publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sujan Shresta sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 134 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sujan Shresta D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sujan Shresta sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sujan Shresta is affiliated with the La Jolla Institute For Allergy & Immunology in the United States and focuses their research primarily in the field of Medicine, with significant specialization in Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Immunology, and Genetics.

Their research covers a broad range of topics, prominently including:

  • Mosquito-borne diseases and control
  • SARS-CoV-2 and COVID-19 Research
  • Malaria Research and Control
  • Viral Infections and Vectors
  • COVID-19 Clinical Research Studies
  • Virology and Viral Diseases
  • Viral gastroenteritis research and epidemiology

Among their recent academic contributions are the following papers:

  • "Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade" (2020, JCI Insight)
  • "Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections" (2020, Journal of Medicinal Chemistry)
  • "A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity" (2022, Cell Reports)
  • "Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2" (2020, Trends in Microbiology)
  • "CD4+ T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection" (2020, Cell Reports)

Frequent collaborators include:

  • Annie Elong Ngono (21 collaborations)
  • Kenneth Kim (15 collaborations)
  • Erica Ollmann Saphire (14 collaborations)
  • Kristen Valentine (14 collaborations)
  • Ying-Ting Wang (11 collaborations)

Shresta publishes regularly in several scientific venues with the highest number of publications in:

  • The Journal of Immunology (7 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (6 publications)
  • Cell Reports (4 publications)
  • Nature Communications (4 publications)
  • Antiviral Research (3 publications)

Best Publications

  • ICOS co-stimulatory receptor is essential for T-cell activation and function.

    Chen Dong;Amy E. Juedes;Ulla Angela Temann;Ulla Angela Temann;Sujan Shresta

  • Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells

    Jonathan W. Heusel;Robin L. Wesselschmidt;Sujan Shresta;John H. Russell

  • Modified mRNA Vaccines Protect against Zika Virus Infection.

    Justin M. Richner;Sunny Himansu;Kimberly A. Dowd;Scott L. Butler

  • Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

    Daniela Weiskopf;Michael A. Angelo;Elzinandes L. de Azeredo;John Sidney

  • How do cytotoxic lymphocytes kill their targets

    Sujan Shresta;Christine Tn Pham;Dori A Thomas;Timothy A Graubert

  • Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

    Sujan Shresta;Kristin L. Sharar;Daniil M. Prigozhin;P. Robert Beatty

  • A Protective Role for Dengue Virus-Specific CD8+ T Cells

    Lauren E. Yauch;Raphaël M. Zellweger;Maya F. Kotturi;Afrina Qutubuddin

  • Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

    Raphaël M. Zellweger;Tyler R. Prestwood;Sujan Shresta

  • Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical

    Sujan Shresta;Jennifer L. Kyle;Heidi M. Snider;Manasa Basavapatna

  • Zika Virus Infects Neural Progenitors in the Adult Mouse Brain and Alters Proliferation

    Hongda Li;Laura Saucedo-Cuevas;Laura Saucedo-Cuevas;Jose A. Regla-Nava;Guoliang Chai;Guoliang Chai

  • Immune Response to Dengue and Zika.

    Annie Elong Ngono;Sujan Shresta

  • Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells

    Sujan Shresta;Debra M. Macivor;Jonathan W. Heusel;John H. Russell

  • Mapping and Role of the CD8 + T Cell Response During Primary Zika Virus Infection in Mice.

    Annie Elong Ngono;Edward A. Vizcarra;William W. Tang;Nicholas Sheets

  • Mouse models of dengue virus infection and disease.

    Lauren E. Yauch;Sujan Shresta

  • CorrectionModified mRNA Vaccines Protect against Zika Virus Infection

    Justin M. Richner;Sunny Himansu;Kimberly A. Dowd;Scott L. Butler

  • Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8 + T cells

    Jinsheng Wen;William Weihao Tang;Nicholas Sheets;Julia Ellison

  • CD4 + T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8 + T Cell or Antibody Responses but Contribute to Protection after Vaccination

    Lauren E. Yauch;Tyler R. Prestwood;Monica M. May;Malika M. Morar

  • STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.

    Stuart T. Perry;Michael D. Buck;Steven M. Lada;Christian Schindler

  • A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication

    William Weihao Tang;Matthew Perry Young;Anila Mamidi;Jose Angel Regla-Nava

  • Critical Roles for Both STAT1-Dependent and STAT1-Independent Pathways in the Control of Primary Dengue Virus Infection in Mice

    Sujan Shresta;Kristin L. Sharar;Daniil M. Prigozhin;Heidi M. Snider

  • Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge

    Jinsheng Wen;Jinsheng Wen;Annie Elong Ngono;Jose Angel Regla-Nava;Kenneth Kim

  • Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice.

    Sujan Shresta;Jennifer L Kyle;P Robert Beatty;Eva Harris

  • A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads

    Tyler R. Prestwood;Daniil M. Prigozhin;Kristin L. Sharar;Raphaël M. Zellweger

Frequent Co-Authors

Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Bjoern Peters
Bjoern Peters La Jolla Institute For Allergy & Immunology
Daniela Weiskopf
Daniela Weiskopf La Jolla Institute For Allergy & Immunology
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology
Joseph G. Gleeson
Joseph G. Gleeson University of California, San Diego
Eva Harris
Eva Harris University of California, Berkeley
Jason A. Greenbaum
Jason A. Greenbaum La Jolla Institute For Allergy & Immunology
Carolyn B. Coyne
Carolyn B. Coyne Duke University
Kelly L. Warfield
Kelly L. Warfield United States Department of the Army

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many professionals begin with foundational nursing education before specializing. Non-nurses can enter the healthcare industry through online nursing programs for non nurses, which offer a pathway to becoming registered nurses and eventually advanced practice providers.

Accelerated options, such as accelerated FNP programs, enable students with prior degrees to quickly transition into Family Nurse Practitioner roles. This fast track is valuable for those seeking to enter clinical practice sooner while maintaining strong patient care foundations.

For those already practicing as Family Nurse Practitioners, specialized training can facilitate a move into more intensive settings. Guidance on fnp to acute care np transitions is critical for advancing skills and expanding clinical responsibilities in treating complex immunological conditions.

Salary variations by specialty highlight the importance of selecting the right career path. Reviewing reports on dnp salary by specialty can help professionals align their ambitions with financial goals while making impactful contributions in immunology and related healthcare fields.

Best Scientists Citing Sujan Shresta

Trending Scientists

Recently Published Articles